# Roxane Laboratories clinical trials: 99 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 99 trials with Roxane Laboratories as lead sponsor, 0 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Roxane Laboratories: 99 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/roxane-laboratories

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 99
- Recruiting or not yet: 0
- Read on: November 19, 2026

## Trials

The 25 newest of 99, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| January 7, 2016 | NCT02649478 | Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate | Roxane Laboratories | Not applicable | Completed | Asthma | 1,430 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02649478) |
| July 19, 2013 | NCT01903122 | Crossover Bioequivalence Study of Cevimeline 30 mg Capsules Under Fasted Conditions | Roxane Laboratories | Early phase 1 | Completed | Dry Mouth | 26 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01903122) |
| July 19, 2013 | NCT01903109 | Crossover Bioequivalence Study of Cevimeline 30 mg Capsules Under Fed Conditions | Roxane Laboratories | Early phase 1 | Completed | Dry Mouth | 27 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01903109) |
| October 23, 2012 | NCT01712139 | Crossover Bioequivalence Study of Irbesartan HCTZ 300/25 mg Tablets Under Fasted Conditions | Roxane Laboratories | Not applicable | Completed | Hypertension | 37 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01712139) |
| October 23, 2012 | NCT01712126 | Crossover Bioequivalence Study of Irbesartan Hydrochlorothiazide 300/25 mg Tablets Under Fed Conditions | Roxane Laboratories | Not applicable | Completed | Hypertension | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01712126) |
| October 23, 2012 | NCT01712113 | Crossover Bioequivalence Study of Irbesartan 300 mg Tablets Under Fasted Conditions | Roxane Laboratories | Not applicable | Completed | Hypertension | 33 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01712113) |
| October 23, 2012 | NCT01712100 | Crossover Bioequivalence Study of Irbesartan 300 mg Tablets Under Fed Conditions | Roxane Laboratories | Not applicable | Completed | Hypertension | 34 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01712100) |
| October 10, 2012 | NCT01703468 | Crossover Bioequivalence Study of Oxcarbazepine 600 mg Suspension Under Fed Conditions | Roxane Laboratories | Phase 1 | Completed | Seizures | 59 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01703468) |
| October 8, 2012 | NCT01702623 | Crossover Bioequivalence Study of Oxcarbazepine 600 mg Suspension Under Fasted Conditions | Roxane Laboratories | Phase 1 | Completed | Seizures | 64 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01702623) |
| August 31, 2012 | NCT01676493 | A Study of Oral Codeine Sulfate in Pediatric Patients With Post-procedural Pain | Roxane Laboratories | Phase 3 | Terminated | Pain | 31 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01676493) |
| August 8, 2012 | NCT01659931 | Bioequivalency Study of Montelukast 10 mg Tablets Under Fasted Conditions | Roxane Laboratories | Early phase 1 | Completed | Asthma | 34 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01659931) |
| August 8, 2012 | NCT01659918 | Bioequivalency Study of Montelukast 10 mg Tablets Under Fed Conditions | Roxane Laboratories | Early phase 1 | Completed | Asthma | 35 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01659918) |
| August 8, 2012 | NCT01659905 | Bioequivalency Study of Montelukast Chewable 5 mg Tablets Under Fasted Conditions | Roxane Laboratories | Early phase 1 | Completed | Asthma | 35 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01659905) |
| August 8, 2012 | NCT01659892 | Bioequivalency Study of Montelukast Chewable 5 mg Tablets Under Fed Conditions | Roxane Laboratories | Early phase 1 | Completed | Asthma | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01659892) |
| May 4, 2012 | NCT01591889 | Crossover Bioequivalence Study of Tinidazole 500 mg Tablets Under Fed Conditions | Roxane Laboratories | Phase 1 | Completed | Trichomoniasis | 28 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01591889) |
| April 4, 2012 | NCT01570959 | Crossover Bioequivalence Study of Quetiapine Fumarate 300 mg Tablets Under Steady State Fasted Conditions | Roxane Laboratories | Not applicable | Completed | Bipolar I Disorder | 56 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01570959) |
| April 4, 2012 | NCT01570907 | Crossover Bioequivalence Study of Quetiapine Fumarate 25 mg Tablets Under Fasted Conditions | Roxane Laboratories | Not applicable | Completed | Treatment for Bipolar I Disorder | 42 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01570907) |
| April 4, 2012 | NCT01570894 | Crossover Bioequivalence Study of Quetiapine Fumarate 25 mg Tablets Under Fed Conditions | Roxane Laboratories | Not applicable | Completed | Bipolar I Disorder | 42 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01570894) |
| June 7, 2011 | NCT01367652 | Bioequivalency Study of Letrozole 2.5 mg Tablets Under Fasted Conditions | Roxane Laboratories | Phase 1 | Completed | Breast Cancer | 28 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01367652) |
| June 7, 2011 | NCT01367626 | Bioequivalency Study of Letrozole 2.5 mg Tablets Under Fed Conditions | Roxane Laboratories | Phase 1 | Completed | Breast Cancer | 28 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01367626) |
| April 8, 2011 | NCT01331447 | Pilot Bioequivalency Study of Exemestane 25 mg Tablet Under Fasted Conditions | Roxane Laboratories | Not applicable | Completed | Breast Cancer | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01331447) |
| April 8, 2011 | NCT01331434 | Bioequivalency Study of Exemestane 25 mg Tablet Under Fed Conditions | Roxane Laboratories | Not applicable | Completed | Breast Cancer | 47 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01331434) |
| April 8, 2011 | NCT01331421 | Bioequivalency Study of Exemestane 25 mg Tablet Under Fasted Conditions | Roxane Laboratories | Not applicable | Completed | Breast Cancer | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01331421) |
| March 24, 2011 | NCT01322360 | Safety and Pharmacokinetic Study of Oral Morphine Sulfate in Pediatric Subjects | Roxane Laboratories | Phase 4 | Completed | Pain | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01322360) |
| March 23, 2011 | NCT01321515 | Bioequivalency Study of Famciclovir 500 mg Tablets Under Fasted Conditions | Roxane Laboratories | Not applicable | Completed | Herpes | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01321515) |

## By phase

| Phase | Trials |
| --- | --- |
| Early phase 1 | 6 |
| Phase 1 | 10 |
| Phase 3 | 1 |
| Phase 4 | 1 |
| Not applicable | 81 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 98 |
| Terminated | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Hypertension | 12 |
| Pain | 11 |
| Seizures | 9 |
| Breast Neoplasms | 7 |
| Xerostomia | 6 |
| Asthma | 5 |
| Bipolar Disorder | 4 |
| Depression | 4 |
| Epilepsy | 3 |
| Sleep Initiation and Maintenance Disorders | 2 |
| Infections | 2 |
| Nausea | 2 |
| Vomiting | 2 |
| Onychomycosis | 2 |
| Herpes Simplex | 2 |
| Essential Hypertension | 2 |
| Edema | 2 |
| Herpes Zoster | 2 |
| Herpes Genitalis | 2 |
| Parkinson Disease | 2 |
| Restless Legs Syndrome | 2 |
| Colitis, Ulcerative | 2 |
| Angina, Stable | 2 |
| Angina Pectoris, Variant | 2 |
| Inflammation | 2 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Laboratories in the United States](https://specstream.ai/data/businesses/laboratories/united-states)
- [Children's hospitals in the United States](https://specstream.ai/data/businesses/childrens-hospitals/united-states)
- [Siding contractors in the United States](https://specstream.ai/data/businesses/siding-contractors/united-states)
- [Home inspectors in the United States](https://specstream.ai/data/businesses/home-inspectors/united-states)
- [B2B oil and gas equipment companies in the United States](https://specstream.ai/data/businesses/b2b-oil-and-gas-equipment-companies/united-states)
- [Plasterers in the United States](https://specstream.ai/data/businesses/plasterers/united-states)
